Discovery of novel ID2 antagonists from pharmacophore-based virtual screening as potential therapeutics for glioma
G. Zhong, Y. Wang, Q. Wang…·B. Lin
This study identifies AK-778-XXMU as a potent ID2 antagonist with potential as a glioma therapeutic through pharmacophore-based virtual screening and experimental validation.